Author:
Ferry Isabelle,Kolesnikov-Gauthier Hélène,Oudoux Aurore,Cougnenc Olivier,Schleiermacher Gudrun,Michon Jean,Bogart Emilie,Chastagner Pascal,Proust Stéphanie,Valteau-Couanet Dominique,Defachelles Anne-Sophie
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Oncology,Hematology,Pediatrics, Perinatology, and Child Health
Reference33 articles.
1. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival;DuBois;J Pediatr Hematol Oncol,1999
2. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial;Ladenstein;Lancet Oncol,2017
3. Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials;Ladenstein;Eur J Nucl Med Mol Imaging,2018
4. Validation of postinduction curie scores in high-risk neuroblastoma: a Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1;Yanik;J Nucl Med,2018
5. Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine;Treuner;Lancet,1984
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献